Insight Molecular Diagnostics (IMDX) EBITDA Margin Growth (3y) (2023 - 2026)
Insight Molecular Diagnostics (IMDX) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 263.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -168.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 360.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -56.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -247.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 4,378.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 2,862.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 146.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 20.00 |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | -3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.04 Mn |
| Dec 31, 2025 | -176,550.00 |
| Sep 30, 2025 | 2,127.00 |
| Jun 30, 2025 | -46,740.00 |
| Mar 31, 2025 | -2,902.00 |
| Dec 31, 2024 | -126,877.00 |
| Sep 30, 2024 | -347,400.00 |
| Jun 30, 2024 | -378,547.00 |
| Mar 31, 2024 | -184,898.00 |
| Dec 31, 2023 | -177,287.00 |
| Sep 30, 2023 | -39,314.00 |
| Jun 30, 2023 | 434,011.00 |
| Mar 31, 2023 | 5.47 Mn |